BrdU incorporation can be used to assess the proliferation status of tissues of
transgenic mice. Embryos in utero can be labeled by injection of BrdU into pregnant
female mice; postnatal animals can be labeled by direct intraperitoneal injection of
BrdU. The quantity of BrdU and the labeling time must be tailored to the tissue of
interest. We provide a protocol below that works well for craniofacial tissues
Saturday, April 11, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment